Results 231 to 240 of about 134,745 (361)

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

Interplay between inflammatory reflex and energetic metabolism in endotoxaemia: A role for haem oxygenase 1?

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 16, Page 3695-3709, August 2025.
Inflammation is vital for defence against injury and infection, but excessive inflammation can lead to tissue damage and disease. The central nervous system (CNS) helps regulate immune responses through neuroendocrine pathways, such as the hypothalamic–pituitary–adrenal axis and the anti‐inflammatory reflex, which limit systemic inflammation.
Evelin C. Cárnio   +5 more
wiley   +1 more source

Effect of Corticosterone on Gene Expression in the Context of Global Hippocampal Transcription. [PDF]

open access: yesInt J Mol Sci
Juszczak GR   +4 more
europepmc   +1 more source

Osteocalcin Ameliorates CUMS‐Induced Depressive‐Like Behaviors by Reducing Mitochondrial Damage in Hippocampal Neurons

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 8, August 2025.
After being secreted by osteoblasts, osteocalcin crosses the blood–brain barrier and interacts with GPCR receptors on hippocampal neurons. This interaction triggers a PKA‐dependent activation of the AMPK/PGC1 pathway, which, in turn, promotes the stabilization of mitochondrial function, leading to an improvement in depressive‐like behaviors in mice ...
Hui Chen   +9 more
wiley   +1 more source

Epigenetic study of the long-term effects of gulf War illness. [PDF]

open access: yesFront Genet
Jones BC   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy